Our US Science Director, Dr Katya Tsaioun, has been selected to serve as a member of the Center for Scientific Review for the US National Institutes of Health. This immensely prestigious appointment is in recognition of Katya’s expertise and achievements, and will make a valuable contribution to medical research in the field of drug discovery for the nervous system. Katya is a highly-regarded expert on in vitro methods in drug development and is the founder of Apredica and Pharma Launcher.
A further great honour for us is that Katya will be presenting a poster at the prestigious Gordon Research Conference on Cellular & Molecular Mechanisms of Toxicity from August 11-16. The poster will outline Safer Medicines Trust’s groundbreaking proposal to compare the relative abilities of animal tests and human-based in vitro tests to predict the safety of medicines.